NCT00104442View on ClinicalTrials.gov

Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

April 30, 2006

Conditions
Alzheimer's Disease
Interventions
DRUG

Rivastigmine

Trial Locations (1)

07936

Novartis Pharmaceuticals, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY